Recent studies have identified insulinoma-associated protein 1 (INSM1) as a sensitive and specific neuroendocrine marker for the diagnosis of all neuroendocrine tumors including SCLC [14,15]. The gene discussed is INSM1; the disease is neuroendocrine neoplasm.